Cargando…

B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab

OBJECTIVE: Patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired humoral immune response to anti–SARS–CoV‐2 vaccine. However, the complex relationship between antigen‐specific B cells an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefanski, Ana‐Luisa, Rincon‐Arevalo, Hector, Schrezenmeier, Eva, Karberg, Kirsten, Szelinski, Franziska, Ritter, Jacob, Jahrsdörfer, Bernd, Schrezenmeier, Hubert, Ludwig, Carolin, Sattler, Arne, Kotsch, Katja, Chen, Yidan, Claußnitzer, Anne, Haibel, Hildrun, Proft, Fabian, Guerra, Gabriela, Durek, Pawel, Heinrich, Frederik, Ferreira‐Gomes, Marta, Burmester, Gerd R., Radbruch, Andreas, Mashreghi, Mir‐Farzin, Lino, Andreia C., Dörner, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2022
Materias:	COVID‐19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011692/ https://www.ncbi.nlm.nih.gov/pubmed/34962360 http://dx.doi.org/10.1002/art.42060

Ejemplares similares

Persistent but atypical germinal center reaction among 3(rd) SARS-CoV-2 vaccination after rituximab exposure
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022)

B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients
por: Stefanski, Ana-Luisa, et al.
Publicado: (2022)

Altered increase in STAT1 expression and phosphorylation in severe COVID‐19
por: Rincon‐Arevalo, Hector, et al.
Publicado: (2021)

Induction of cross-reactive, mucosal anti-SARS-CoV-2 antibody responses in rheumatoid arthritis patients after 3rd dose of COVID-19 vaccination
por: Bondareva, M., et al.
Publicado: (2022)

Deep Phenotyping of CD11c(+) B Cells in Systemic Autoimmunity and Controls
por: Rincon-Arevalo, Hector, et al.
Publicado: (2021)

BTLA Expression and Function Are Impaired on SLE B Cells
por: Wiedemann, Annika, et al.
Publicado: (2021)

CD39 and CD326 Are Bona Fide Markers of Murine and Human Plasma Cells and Identify a Bone Marrow Specific Plasma Cell Subpopulation in Lupus
por: Dang, Van Duc, et al.
Publicado: (2022)

Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis
por: Gatto, Mariele, et al.
Publicado: (2019)

SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation
por: Sattler, Arne, et al.
Publicado: (2022)

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
por: Schrezenmeier, Eva, et al.
Publicado: (2022)

Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases
por: Weißenberg, Sarah Y., et al.
Publicado: (2019)

CD27(+)IgD(−) B cells in the peripheral blood of colorectal cancer patients: on anti-tumor or tumor-protective mission?
por: Jahrsdörfer, Bernd, et al.
Publicado: (2014)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study
por: Schally, Julia, et al.
Publicado: (2022)

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study
por: Proft, Fabian, et al.
Publicado: (2022)

Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
por: Proft, Fabian, et al.
Publicado: (2022)

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

ATP promotes immunosuppressive capacities of mesenchymal stromal cells by enhancing the expression of indoleamine dioxygenase
por: Lotfi, Ramin, et al.
Publicado: (2018)

Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipients
por: Thole, Linda Marie Laura, et al.
Publicado: (2023)

Efficient CRISPR-Cas9-mediated mutagenesis in primary human B cells for identifying plasma cell regulators
por: Le, Tuan Anh, et al.
Publicado: (2022)

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
por: Körper, Sixten, et al.
Publicado: (2022)

Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial
por: Proft, Fabian, et al.
Publicado: (2021)

SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome
por: Rose, Thomas, et al.
Publicado: (2016)

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents
por: Jahrsdörfer, Bernd, et al.
Publicado: (2021)

Phorbol-12-myristate-13-acetate is a potent enhancer of B cells with a granzyme B(+) regulatory phenotype
por: Veh, Johanna, et al.
Publicado: (2023)

Questioning whether IgM Fc receptor (FcµR) is expressed by innate immune cells
por: Skopnik, Christopher M., et al.
Publicado: (2022)

Human CD27+ memory B cells colonize a superficial follicular zone in the palatine tonsils with similarities to the spleen. A multicolor immunofluorescence study of lymphoid tissue
por: Lettau, Marie, et al.
Publicado: (2020)

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
por: Torgutalp, Murat, et al.
Publicado: (2022)

Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers
por: Weiß, Anja, et al.
Publicado: (2014)

Nonfollicular reactivation of bone marrow resident memory CD4 T cells in immune clusters of the bone marrow
por: Siracusa, Francesco, et al.
Publicado: (2018)

Relation of α(2)-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis
por: Hoppe, Berthold, et al.
Publicado: (2020)

Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis
por: Hoppe, Berthold, et al.
Publicado: (2021)

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
por: Protopopov, Mikhail, et al.
Publicado: (2017)

CD69(+) memory T lymphocytes of the bone marrow and spleen express the signature transcripts of tissue‐resident memory T lymphocytes
por: Siracusa, Francesco, et al.
Publicado: (2019)

Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
por: Weinstock, Christof, et al.
Publicado: (2021)

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages
por: Jahrsdörfer, Bernd, et al.
Publicado: (2022)

Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
por: Heinzel, Andreas, et al.
Publicado: (2022)

Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
por: Baraliakos, Xenofon, et al.
Publicado: (2013)

Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data
por: Redeker, Imke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uf7o3bfs645o810m5olo6sutqa